Annual Revenue
$250.01 M
+$209.10 M+511.16%
December 31, 2023
Summary
- As of February 7, 2025, VYGR annual revenue is $250.01 million, with the most recent change of +$209.10 million (+511.16%) on December 31, 2023.
- During the last 3 years, VYGR annual revenue has risen by +$78.88 million (+46.09%).
- VYGR annual revenue is now at all-time high.
Performance
VYGR Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$24.63 M
-$4.95 M-16.73%
September 30, 2024
Summary
- As of February 7, 2025, VYGR quarterly revenue is $24.63 million, with the most recent change of -$4.95 million (-16.73%) on September 30, 2024.
- Over the past year, VYGR quarterly revenue has dropped by -$65.43 million (-72.65%).
- VYGR quarterly revenue is now -83.63% below its all-time high of $150.48 million, reached on March 31, 2023.
Performance
VYGR Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$163.78 M
+$20.02 M+13.92%
September 30, 2024
Summary
- As of February 7, 2025, VYGR TTM revenue is $163.78 million, with the most recent change of +$20.02 million (+13.92%) on September 30, 2024.
- Over the past year, VYGR TTM revenue has dropped by -$86.22 million (-34.49%).
- VYGR TTM revenue is now -34.49% below its all-time high of $250.01 million, reached on December 31, 2023.
Performance
VYGR TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
VYGR Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +511.2% | -72.7% | -34.5% |
| 3 y3 years | +46.1% | +1689.0% | +300.4% |
| 5 y5 years | +3181.4% | +1689.0% | +300.4% |
VYGR Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +568.2% | -83.6% | +1689.0% | -34.5% | +429.6% |
| 5 y | 5-year | at high | +568.2% | -83.6% | +1689.0% | -34.5% | +931.6% |
| alltime | all time | at high | +3181.4% | -83.6% | +1689.0% | -34.5% | +6258.1% |
Voyager Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $24.63 M(-16.7%) | $163.78 M(+13.9%) |
| Jun 2024 | - | $29.58 M(+51.6%) | $143.77 M(+20.8%) |
| Mar 2024 | - | $19.52 M(-78.3%) | $119.04 M(-52.4%) |
| Dec 2023 | $250.01 M(+511.2%) | $90.06 M(+1851.9%) | $250.01 M(+57.8%) |
| Sep 2023 | - | $4.61 M(-4.9%) | $158.40 M(-18.7%) |
| Jun 2023 | - | $4.85 M(-96.8%) | $194.87 M(+2.2%) |
| Mar 2023 | - | $150.48 M(-9808.4%) | $190.73 M(+366.3%) |
| Dec 2022 | $40.91 M(+9.3%) | -$1.55 M(-103.8%) | $40.91 M(-42.0%) |
| Sep 2022 | - | $41.09 M(+5670.5%) | $70.53 M(+128.1%) |
| Jun 2022 | - | $712.00 K(+8.2%) | $30.93 M(-2.0%) |
| Mar 2022 | - | $658.00 K(-97.7%) | $31.57 M(-15.6%) |
| Dec 2021 | $37.41 M(-78.1%) | $28.07 M(+1794.3%) | $37.41 M(+135.6%) |
| Sep 2021 | - | $1.48 M(+9.2%) | $15.88 M(-88.0%) |
| Jun 2021 | - | $1.36 M(-79.1%) | $132.24 M(-17.1%) |
| Mar 2021 | - | $6.50 M(-0.6%) | $159.56 M(-6.8%) |
| Dec 2020 | $171.13 M(+63.9%) | $6.54 M(-94.5%) | $171.13 M(-13.2%) |
| Sep 2020 | - | $117.84 M(+310.9%) | $197.26 M(+97.6%) |
| Jun 2020 | - | $28.68 M(+58.7%) | $99.86 M(-14.8%) |
| Mar 2020 | - | $18.07 M(-44.7%) | $117.26 M(+12.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $104.39 M(+1270.1%) | $32.67 M(+59.9%) | $104.39 M(+41.6%) |
| Sep 2019 | - | $20.43 M(-55.7%) | $73.72 M(+33.1%) |
| Jun 2019 | - | $46.09 M(+786.8%) | $55.39 M(+366.4%) |
| Mar 2019 | - | $5.20 M(+158.8%) | $11.87 M(+55.8%) |
| Dec 2018 | $7.62 M(-24.8%) | $2.01 M(-4.1%) | $7.62 M(-36.3%) |
| Sep 2018 | - | $2.09 M(-18.7%) | $11.96 M(+8.6%) |
| Jun 2018 | - | $2.58 M(+173.4%) | $11.01 M(+14.5%) |
| Mar 2018 | - | $942.00 K(-85.2%) | $9.61 M(-5.2%) |
| Dec 2017 | $10.13 M(-28.7%) | $6.34 M(+452.7%) | $10.13 M(+64.8%) |
| Sep 2017 | - | $1.15 M(-2.5%) | $6.15 M(-26.0%) |
| Jun 2017 | - | $1.18 M(-19.6%) | $8.31 M(-23.4%) |
| Mar 2017 | - | $1.46 M(-38.0%) | $10.85 M(-23.7%) |
| Dec 2016 | $14.22 M(-18.0%) | $2.36 M(-28.6%) | $14.22 M(-15.3%) |
| Sep 2016 | - | $3.31 M(-11.1%) | $16.80 M(-8.8%) |
| Jun 2016 | - | $3.72 M(-23.0%) | $18.42 M(-5.9%) |
| Mar 2016 | - | $4.83 M(-2.2%) | $19.59 M(+13.0%) |
| Dec 2015 | $17.33 M | $4.94 M(0.0%) | $17.33 M(+39.8%) |
| Sep 2015 | - | $4.94 M(+1.1%) | $12.40 M(+66.2%) |
| Jun 2015 | - | $4.88 M(+89.6%) | $7.46 M(+189.6%) |
| Mar 2015 | - | $2.58 M | $2.58 M |
FAQ
- What is Voyager Therapeutics annual revenue?
- What is the all time high annual revenue for Voyager Therapeutics?
- What is Voyager Therapeutics annual revenue year-on-year change?
- What is Voyager Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Voyager Therapeutics?
- What is Voyager Therapeutics quarterly revenue year-on-year change?
- What is Voyager Therapeutics TTM revenue?
- What is the all time high TTM revenue for Voyager Therapeutics?
- What is Voyager Therapeutics TTM revenue year-on-year change?
What is Voyager Therapeutics annual revenue?
The current annual revenue of VYGR is $250.01 M
What is the all time high annual revenue for Voyager Therapeutics?
Voyager Therapeutics all-time high annual revenue is $250.01 M
What is Voyager Therapeutics annual revenue year-on-year change?
Over the past year, VYGR annual revenue has changed by +$209.10 M (+511.16%)
What is Voyager Therapeutics quarterly revenue?
The current quarterly revenue of VYGR is $24.63 M
What is the all time high quarterly revenue for Voyager Therapeutics?
Voyager Therapeutics all-time high quarterly revenue is $150.48 M
What is Voyager Therapeutics quarterly revenue year-on-year change?
Over the past year, VYGR quarterly revenue has changed by -$65.43 M (-72.65%)
What is Voyager Therapeutics TTM revenue?
The current TTM revenue of VYGR is $163.78 M
What is the all time high TTM revenue for Voyager Therapeutics?
Voyager Therapeutics all-time high TTM revenue is $250.01 M
What is Voyager Therapeutics TTM revenue year-on-year change?
Over the past year, VYGR TTM revenue has changed by -$86.22 M (-34.49%)